raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:404

Familial hyperaldosteronism type II

Synonyms: FH-II · FH2 · Familial hyperaldosteronism type 2

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult
Status
active

A heritable form of primary aldosteronism (PA) characterized by hypertension of varying severity, non-glucocorticoid remediable hyperaldosteronism, variable hypokalemia, low plasma renin activity (PRA) and increased aldosterone-to-renin ratio.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFamilial hyperaldosteronism type IIFH-II · FH2 · Familial hyperaldosteronism type 2
frHyperaldostéronisme familial type IIFH-II · FH2 · Hyperaldostéronisme familial type 2
deHyperaldosteronismus, familiärer, Typ IIFH-II · FH2 · Familiärer Hyperaldosteronismus, Typ 2
esHiperaldosteronismo familiar tipo IIFH-II · FH2 · Hiperaldosteronismo familiar tipo 2
itIperaldosteronismo familiare, tipo IIFH-II · FH2 · Iperaldosteronismo familiare, tipo 2
nlFamiliaal hyperaldosteronisme type IIFH-II · FH2 · Familiaal hyperaldosteronisme type 2
ptHiperaldosteronismo familiar tipo IIFH-II · FH2 · Hiperaldosteronismo familiar tipo 2
plRodzinny hiperaldosteronizm typu IIFH2 · FH-II · Rodzinny gruczolak nadnerczy · Rodzinny hiperaldosteronizm typu 2
csFamiliární hyperaldosteronismus, typ IIFH-II · FH2 · Familiární adrenální adenom · Familiární hyperaldosteronismus, typ 2
ukСімейний гіперальдостеронізм, тип IIСімейна аденома надниркових залоз · Сімейний гіперальдостеронізм 2 типу · FH2 · FH-II
zh家族性醛固酮增多症II型家族性醛固酮增多症II型
trAilesel hiperaldosteronizm tip IIFH2 · FH-II · Ailesel adrenal adenom · Ailesel hiperaldosteronizm tip 2

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM605635Evalidated
ICD-10E26.0NTBTinclusionvalidated
ICD-115A72.0NTBTindexvalidated
MONDO0011576Evalidated
MeSHC565312Evalidated
UMLSC1854107Evalidated
GARD2789Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CLCN2Disease-causing germline mutation(s) inAssessedHGNC:2020ENSG000001148596005703q27.1chloride voltage-gated channel 229403011[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

14 annotations · validated 2016-08-29
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0000822Hypertension
Very frequent (99-80%)
HP:0040084Abnormal circulating renin
HP:0011740Glucocortocoid-insensitive primary hyperaldosteronism
Frequent (79-30%)
HP:0011746Secretory adrenocortical adenoma
Occasional (29-5%)
HP:0008221Adrenal hyperplasia
HP:0000421Epistaxis
HP:0002315Headache
HP:0002900Hypokalemia
HP:0002170Intracranial hemorrhage
HP:0200114Metabolic alkalosis
HP:0001324Muscle weakness
HP:0002018Nausea
HP:0000360Tinnitus
Excluded (0%)
HP:0011739Dexamethasone-suppresible primary hyperaldosteronism

Run the differential on the 3 obligate / very frequent terms

Annotation source: 20927129[PMID]_26934393[PMID]_27036860[PMID]_25667376[PMID]_20927129[PMID]_1521363[PMID]_9745430[PMID]_11073536[PMID]

7

Sources for this card